Duloxetine-induced rapid eye movement sleep behavior disorder: a case report

被引:13
作者
Tan, Lu [1 ]
Zhou, Junying [1 ]
Yang, Linghui [1 ]
Ren, Rong [1 ]
Zhang, Ye [1 ]
Li, Taomei [1 ]
Tang, Xiangdong [1 ]
机构
[1] Sichuan Univ, West China Hosp, Sleep Med Ctr, Lab Anaesthesia & Crit Care Med,Translat Neurosci, Chengdu, Sichuan, Peoples R China
基金
中国国家自然科学基金;
关键词
Duloxetine; Rapid eye movement sleep behavior disorder; Polysomnography; REM-SLEEP; MUSCLE TONE; ANTIDEPRESSANTS; ATONIA; DEPRESSION;
D O I
10.1186/s12888-017-1535-4
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Tricyclic antidepressants and selective serotonin reuptake inhibitors have been reported to induce the symptoms of rapid eye movement (REM) sleep behavior disorder (RBD) or to exacerbate REM sleep without atonia. With this case report, we found an association between typical RBD and duloxetine, a serotonin-noradrenaline reuptake inhibitor. Case presentation: We present a case of a 62-year-old woman who experienced enactment behaviors with violent dreams that were associated with increased tonic or phasic chin electromyography activity during REM sleep after treated with duloxetine. RBD symptoms were gradually reduced and completely ceased after discontinuation of duloxetine for 37 days. Conclusion: The current case appears to be the first observation of duloxetine-induced RBD. We describe features of RBD induced by duloxetine that are similar and different from that induced by tricyclic antidepressants and selective serotonin reuptake inhibitors.
引用
收藏
页数:5
相关论文
共 23 条
[1]  
American Academy of Sleep Medicine, 2007, AM AC SLEEP MED SCOR
[2]  
Applebee GA, 2009, J CLIN SLEEP MED, V5, P477
[3]   Acute effects of paroxetine on genioglossus activity in obstructive sleep apnea [J].
Berry, RB ;
Yamaura, EM ;
Gill, K ;
Reist, C .
SLEEP, 1999, 22 (08) :1087-1092
[4]  
Cygan F, 2010, J CLIN SLEEP MED, V6, P551
[5]   Comorbidity and medication in REM sleep behavior disorder A multicenter case-control study [J].
Frauscher, Birgit ;
Jennum, Poul ;
Ju, Yo-El S. ;
Postuma, Ronald B. ;
Arnulf, Isabelle ;
De Cock, Valerie Cochen ;
Dauvilliers, Yves ;
Fantini, Maria L. ;
Ferini-Strambi, Luigi ;
Gabelia, David ;
Iranzo, Alex ;
Leu-Semenescu, Smaranda ;
Mitterling, Thomas ;
Miyamoto, Masayuki ;
Miyamoto, Tomoyuki ;
Montplaisir, Jacques Y. ;
Oertel, Wolfgang ;
Pelletier, Amelie ;
Prunetti, Paolo ;
Puligheddu, Monica ;
Santamaria, Joan ;
Sonka, Karel ;
Unger, Marcus ;
Wolfson, Christina ;
Zucconi, Marco ;
Terzaghi, Michele ;
Hoegl, Birgit ;
Mayer, Geert ;
Manni, Raffaele .
NEUROLOGY, 2014, 82 (12) :1076-1079
[6]   Update on the pharmacology of REM sleep behavior disorder [J].
Gagnon, Jean-Francois ;
Postuma, Ronald B. ;
Montplaisir, Jacques .
NEUROLOGY, 2006, 67 (05) :742-747
[7]   Effect of two antidepressant drugs on REM sleep and EMG activity during sleep [J].
Jobert, M ;
Jähnig, P ;
Schulz, H .
NEUROPSYCHOBIOLOGY, 1999, 39 (02) :101-109
[8]   Rapid eye movement sleep behavior disorder in adults younger than 50 years of age [J].
Ju, Yo-El S. .
SLEEP MEDICINE, 2013, 14 (08) :768-774
[9]   Duloxetine increases stage 3 sleep and suppresses rapid eye movement (REM) sleep in patients with major depression [J].
Kluge, Michael ;
Schussler, Petra ;
Steiger, Axel .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 (08) :527-531
[10]   SUPPRESSION OF HYPOGLOSSAL MOTONEURONS DURING THE CARBACHOL-INDUCED ATONIA OF REM-SLEEP IS NOT CAUSED BY FAST SYNAPTIC INHIBITION [J].
KUBIN, L ;
KIMURA, H ;
TOJIMA, H ;
DAVIES, RO ;
PACK, AI .
BRAIN RESEARCH, 1993, 611 (02) :300-312